Sio Capital Management, LLC
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACOR, Quotient Ltd shs, SNY, GSK, PHG, and represent 38.82% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ACOR (+$21.95M), BIIB (+$7.56M), Sage Therapeutics (+$7.31M), Puma Biotechnology Inc Common Stock (+$5.95M), MRK (+$5.08M), TMO, JNJ, PFE, SNY, Medtronic.
- Started 27 new stock positions in ALNY, Puma Biotechnology Inc Common Stock, MOH, Anthera Pharmaceutcls, Insmed Inc, Inotek Pharmaceuticals, Flamel Technologies Sa, Medtronic, PFE, Quintiles Transnatio Hldgs I.
- Reduced shares in these 10 stocks: ACAD (-$16.24M), AMGN (-$9.71M), CERN (-$7.60M), CAH (-$6.60M), HRC (-$5.98M), , ZMH, Walgreen Boots Alliance, , Allergan.
- Sold out of its positions in ACAD, Aclaris Therapeutics, Actinium Pharmaceuticals, Adamas Pharmaceuticals, AMGN, EW, FLML, HRC, HUM, IMMU. BABY, Sarepta Therapeutics, SYK, Walgreen Boots Alliance, ZMH, Zoetis Inc Cl A, Allergan, Perrigo Company.
- Sio Capital Management was a net seller of stock by $9.46M.
- Sio Capital Management has $178.78M in assets under management (AUM), growing by 4.31%.
Sio Capital Management portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Acorda Therapeutics (ACOR) | 12.28 | 1.05M NEW | 21.00 | 18.70 |
| Quotient Ltd shs | 9.14 | 2.34M +4.00% | 6.99 | 0.00 |
| Sanofi-Aventis SA (SNY) | 6.84 | 270422 +28.00% | 45.25 | 48.60 |
| GlaxoSmithKline (GSK) | 6.17 | 261513 -25.00% | 42.16 | 43.62 |
| Koninklijke Philips Electronics NV (PHG) | 4.39 | 244186 -21.00% | 32.11 | 36.77 |
| Biogen Idec (BIIB) | 4.23 | 27650 NEW | 273.42 | 278.60 |
| Sage Therapeutics | 4.09 | 102800 NEW | 71.07 | 0.00 |
| Rigel Pharmaceuticals (RIGL) | 3.50 | 1.89M +49.00% | 3.31 | 2.71 |
| Puma Biotechnology Inc Common Stock | 3.33 | 160064 NEW | 37.20 | 0.00 |
| Tabula Rasa Healthcare | 3.12 | 414045 +6.00% | 13.48 | 0.00 |
| Merck & Co (MRK) | 2.84 | 80000 NEW | 63.54 | 65.46 |
| Eli Lilly & Co. (LLY) | 2.72 | 57786 -13.00% | 84.10 | 82.64 |
| Aetna (AET) | 2.65 | 37100 +85.00% | 127.55 | 152.10 |
| Cardinal Health (CAH) | 2.64 | 57950 -58.00% | 81.55 | 77.48 |
| Thermo Fisher Scientific (TMO) | 2.58 | 30000 NEW | 153.60 | 175.60 |
| Advanced Accelerat spon ads each rep 2 ord shs | 2.42 | 108523 -29.00% | 39.86 | 0.00 |
| Adamis Pharmaceuticals Corp Com Stk | 2.10 | 882862 -16.00% | 4.25 | 0.00 |
| Johnson & Johnson (JNJ) | 2.09 | 30000 NEW | 124.57 | 134.91 |
| UnitedHealth (UNH) | 1.94 | 21151 +30.00% | 164.01 | 184.92 |
| Pfizer (PFE) | 1.91 | 100000 NEW | 34.21 | 33.88 |
| Medtronic | 1.35 | 30000 NEW | 80.57 | 0.00 |
| Smith & Nephew (SNN) | 1.34 | 77244 NEW | 30.93 | 35.32 |
| Molina Healthcare (MOH) | 1.28 | 50000 NEW | 45.60 | 69.73 |
| Teva Pharmaceutical Industries (TEVA) | 1.25 | 69500 NEW | 32.09 | 31.05 |
| Boston Scientific Corporation (BSX) | 1.25 | 90000 -61.00% | 24.87 | 27.91 |
| Chemocentryx | 1.20 | 294150 -9.00% | 7.28 | 0.00 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.19 | 19475 NEW | 109.37 | 134.83 |
| Globus Med Inc cl a | 0.99 | 60000 NEW | 29.62 | 0.00 |
| Quintiles Transnatio Hldgs I | 0.97 | 21500 NEW | 80.51 | 0.00 |
| Insmed Inc | 0.83 | 85000 NEW | 17.51 | 0.00 |
| Inotek Pharmaceuticals | 0.81 | 726900 NEW | 2.00 | 0.00 |
| Coherus Biosciences | 0.75 | 63800 NEW | 21.14 | 0.00 |
| Sunesis Pharmaceuticals Inc Ne | 0.72 | 311925 NEW | 4.10 | 0.00 |
| Aeglea Biotherapeutics | 0.71 | 169889 -9.00% | 7.45 | 0.00 |
| Vocera Communications | 0.69 | 49871 NEW | 24.82 | 0.00 |
| Cerner Corporation (CERN) | 0.66 | 20000 -86.00% | 58.85 | 67.15 |
| Mazor Robotics Ltd. equities | 0.52 | 31465 NEW | 29.78 | 0.00 |
| Flamel Technologies Sa | 0.49 | 91413 NEW | 9.68 | 0.00 |
| Axsome Therapeutics | 0.46 | 210000 NEW | 3.90 | 0.00 |
| Alnylam Pharmaceuticals (ALNY) | 0.39 | 13500 NEW | 51.26 | 84.52 |
| Newlink Genetics Corporation | 0.34 | 25420 NEW | 24.11 | 0.00 |
| Pfenex | 0.28 | 85867 NEW | 5.81 | 0.00 |
| Oasmia Pharmaceutical Ab | 0.21 | 197470 +8.00% | 1.91 | 0.00 |
| Forward Pharma A/s | 0.17 | 14224 -72.00% | 21.51 | 0.00 |
| Biopharmx | 0.09 | 313717 -72.00% | 0.50 | 0.00 |
| Anthera Pharmaceutcls | 0.08 | 333712 NEW | 0.43 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for Sio Capital Management
- Sio Capital Management 2016 Q4 filed Feb. 14, 2017
- Sio Capital Management 2016 Q3 filed Nov. 15, 2016
- Sio Capital Management 2016 Q2 filed Aug. 15, 2016
- Sio Capital Management 2016 Q1 filed May 16, 2016
- Sio Capital Management 2015 Q4 filed Feb. 16, 2016
- Sio Capital Management 2015 Q3 filed Nov. 13, 2015
- Sio Capital Management 2015 Q1 filed May 15, 2015
- Sio Capital Management 2014 Q4 filed Feb. 17, 2015
- Sio Capital Management 2011 Q1 filed May 17, 2011
- Sio Capital Management 2010 Q4 filed Feb. 8, 2011